SODIUM PHOSPHATES (SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE;) — FDA Approval ANDA209997 (FRESENIUS KABI USA)
SODIUM PHOSPHATES (SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE;) — FDA Approval ANDA209997 (FRESENIUS KABI USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SODIUM PHOSPHATES; Active ingredients: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; App
| Brand name | SODIUM PHOSPHATES |
|---|---|
| Active ingredients | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Application number | ANDA209997 |
| Sponsor | FRESENIUS KABI USA |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20220330 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →